YBL-005

N/A

Report date: 2025/01/26 15:40:03

Base Information

Drug NameYBL-005
Drug Alias NameYBL-005
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesY-biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesY-biologics Inc
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A